SOPHiA GENETICS SA
About SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $359.0M
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $359.0M
- Shares outstanding
- 68.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 23, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading 4% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SOPHiA GENETICS SA.
Write a review
News about SOPHiA GENETICS SA
News & sentiment via Polygon.io
